Risk Based Incoming Quality Assurance (IQA)

Similar documents
Technology Transfer Critical Points to Consider

Stability Testing for Pre-Clinical and Early Phase Clinical Drug Products

Considerations when choosing a LIMS System

Supplier Relationship Management

Process Validation for FDA Regulated Industries

Environmental Monitoring Requirements and Best Practices for Medical Devices and Drugs New AAMI and ISO EM Reference Documents and Standards

Understanding Microbiology Related Data Integrity Issues and Their Causes

Filling and Packaging Validation for FDA Regulated Industries

Auditing Microbiology Media Suppliers

Good Microbiology Laboratory Practices

Auditing Cleanroom Gown Suppliers

Auditing Cleanroom Gown Suppliers (Europe & Middle East)

Understanding GxP (GMP, GCP & GLP) for FDA Regulated Industries

Auditing Cleanroom Gown Suppliers

Why Disinfectant Qualification Studies Fail

Environmental Monitoring Deficiencies

Understanding Microbial Control in In-Vitro Diagnostics

Chemical Sterilization - Alternate Sterilization Methods

Pre-Sterilization Bioburden Failures and Causes

Investigating Non-Sterile Product Bioburden Failures

Facility Water Management

CONVENTIONAL AND ALTERNATE STERILIZATION METHODS

Strategy for Investigating Microbial Contaminations

Microbial Detection Methods and Their Limitations

Key Elements of a Microbial Contamination Control Policy Why and how to write a policy for Microbial Contamination Control

Pharmaceutical Water System Sampling The Why s, Where s, and How s of Doing It Right

Microbial Contamination Testing and Validation Challenges Non-Sterile Products and Raw Materials

Cleaning-Disinfection-Sterilization of Reusable Medical Devices

Pharmacopoeial Antimicrobial Effectiveness Testing

Mold Contamination-Do's and Don'ts

Cleaning Validation-Common Errors

Biofilms in Water Systems - Reasons and Solutions

Microrite, Inc. brings you this unique learning experience in Fungal Identification Simplified E-Workshop; Part of

Cleaning-Sterilization-Disinfection Validation of Reusable Medical Devices

Microrite, Inc. brings you this unique learning experience in Biofilm Basics; Part of Microrite s step-by-step webinar series.

MICROBIAL LIMIT TESTS FOR RAW MATERIALS AND NON-STERILE PRODUCTS REVIEW-DISCUSSIONS-INTERPRETATIONS

Contamination Risk Assessment in Aseptic, Non-Sterile and Terminally Sterilized Products March 7 th & 8 th Raleigh, NC

EU GMP ANNEX 1 DRAFT CLARIFICATION AND IMPACT

ADVANCED COURSE IN THE IDENTIFICATION OF FUNGI

Mold Contaminations-Prevention, Investigation, Remediation and Risk Assessment Durham, NC September 17 th & 18 th, 2018

March 14th, 2014 * San Juan, Puerto Rico Identifying, Preventing, Controlling, Investigating and Remediating Mold Contamination

Disinfectant Qualification Bacteria, Fungi, Viruses and Atypical Organisms A Step by Step Workshop

Disinfectant Qualification and Cleanroom Disinfection A Step by Step Workshop

EU GMP ANNEX 1 CHANGES CLARIFICATION AND IMPACT

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)

Quality and GMP Compliance for Virtual Companies (Pharmaceutical, Medical Device & Biologics Industries)

Bring this workshop to your location: For more information, contact PharmaEd Resources at (217) PharmaED

SOPs for FDA-Regulated Industry Best Practices to Withstand FDA Expectations

Applying ISO14971 / IEC62304 / IEC A Practical Guide On How To Implement Risk Management

SOPs for FDA-Regulated Industry: Best Practices to Withstand FDA Expectations

NEW! Processing of cgmp Controlled Raw Materials

Computer System Validation - Reduce Costs and Avoid 483s

When the FDA comes knocking, will your inspection be a success? YES

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (COM) COURSE DESCRIPTION

MEDICAL DEVICE DESIGN Implementing An Approach CONTROL I. Design control in both QSR and ISO 13485:2003 is complicated. Regardless of the complex

Pharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit

Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH)

Risk Based Approach ISO 9001:2015 Internal Auditor Training

Stability Studies for Pharmaceutical Products (API and finished products)

In-Line Inspection of Pipelines

NUSAGE PharmEng. Pharmaceutical and Biotechnology Training Program COMPUTERIZED SYSTEM VALIDATION

ONE DAY EVENT. Learn effective skills and practical solutions for successful leadership.

Medical Device Complaint Management

Effectively Addressing and Remediating FDA's Form 483 Findings, Warning Letters and Consent Decree Compliance Issues

21 CFR Part 11 Compliance for SaaS/Cloud Applications

2 Day Seminar. Supplier Management for Medical Device Manufacturers 12 RAPS CREDITS. Jun Boston

Reduce costs for compliance with data integrity: 21 CFR Part 11, SaaS/Cloud, EU GDPR

NUSAGE PharmEng. Pharmaceutical and Biotechnology Training Program GMP FACILITY DESIGN WITH GOOD ENGINEERING PRACTICE

ASME NQA-1 Certification. Matthew Vazquez September 4, 2017

Medical Device Complaint Management

Avoiding Microbiological Media Related Failures

NUSAGE PharmEng. Pharmaceutical and Biotechnology Training Program FUNDAMENTALS OF MEDICAL DEVICE REGULATORY AFFAIRS

EFFECTIVE PROCESS VALIDATION NUSAGE PharmEng Pharmaceutical and Biotechnology Training Program Copyright 2014 NUSAGE-PharmEng.

When the FDA comes knocking, will your inspection be a success? YES

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

Data Integrity. Requirements for a GMP-compliant Data Life Cycle SPEAKERS: August 2017, Copenhagen, Denmark LEARNING OBJECTIVES:

GMP for Medical Devices

Technical Services Document #: TS-0007 Internal Audit Procedure Version #: 01

GUYANA NATIONAL BUREAU OF STANDARDS SCHEDULE OF TRAINING PROGRAMMES FOR MARCH TO DECEMBER 2018 Manufacturing and Service Organisations

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

Requirements for a GMP-compliant Data Life Cycle May 2016, Berlin, Germany. Karl-Heinz Menges Regierungspräsidium Darmstadt

ISO 9001: Major Revision, Significant Changes

Modern Validation Technology Boot Camp

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

Designing and Sustaining New and Existing Product Stability Testing Program

Analytical Method Validation

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

Understanding and Testing Compressed Gases

RBA Auditor Guidebook

Understanding and Testing Compressed Gases

UNILEVER WHY FSSC 22000

1 General Information Supplier:

Time Management for the Busy Professional

Establishing the Self Inspections and Controls for Ensuring Audits to Confirm Effective Laboratory Data Integrity, Data Integrity Controls,

Audit Trail Review for Computerised Systems in Analytical Laboratories

SKILLED MIGRATION ASSESSMENT APPLICATION FORM 2016

RISK MANAGEMENT. ASQ Orange Empire Section 2017 Quality Day

please fill out here:

Liquid Chromatography Boot Camp Plus For pharmaceutical and Biopharmaceutical industries

Transcription:

Microrite, Inc. brings you this unique learning experience in Risk Based Incoming Quality Assurance (IQA); Part of Microrite s step-by-step webinar series. Risk Based Incoming Quality Assurance (IQA) In addressing regulatory quality system needs for incoming supplied materials & components per ISO13485, GMP compliance, etc. one needs to define quality controls and documentation needs based on inspection tools or lack of. Incoming Quality (IQ) or Receiving Inspection (RI) is done more often by default or standard template then through logic approach based on needs and risks. Results are often limited to lot identity checklist and low value assessment, if any. So how effective and valuable is your incoming quality effort? Processes begin with your suppliers per your design requirements; define the means to ensure higher confidence of success By using risk management approaches and practices, such as ISO14971, one can define supplier process and incoming controls as appropriate due to risk in Critical To Quality (CTQ) materials and components. Defining a better means to implement an overall control approach including ongoing variation and change management. When? September 24 th, 2013 3:00pm to 5:00pm Eastern Standard Time Which industries does this webinar apply to? Pharmaceuticals, Biotechnology, Medical Device, and In Vitro Diagnostics. Who should attend? Quality Assurance, Regulatory Affairs, Clinical Affairs, R&D, Manufacturing, and training personnel.

September 24 th, 2013 This 2 hour course will include: Defining an incoming quality strategy development projects, commercial projects, risk management Early development, characterization is often the key in defining critical feature(s) and risks Receiving inspection scope compliance vs. quality function trade-offs in risk mitigation Tools and gages needs and ongoing demands Calibration and resources options and requirements Qualifying and leveraging the supply base options in incoming quality approaches Defining risk, critical design features, and critical process limits Limited data, low volume realities defining a pilot build plans Defining product qualification criteria first article acceptance and ongoing lot acceptance Non-conformance response and follow up structured problem solving Qualification options & validation roles for incoming quality activities Change management considerations Data demands and management considerations Alternate and second supply sources other business realities (virtual supply chain) Disqualifying suppliers and products considerations Outsourcing portions and other options for incoming controls Regulatory minimums Using risk management for incoming quality and overall product control advantages Who will be teaching? George J. Marcel, has over 30 years experience in quality assurance applications in multiple industries (including medical device, automotive, commercial, green tech (wind power), and other high-tech industries) as a quality professional in roles as director, manager, engineer, supervisor, and project manager. George is a medical device quality consultant with over 15 years experience within the medical device industry. He has hands on experience in implementing quality management systems from start up to implementing correction in commercial systems that required revision due to non-compliance or other gaps including multiple FDA Warning letter responses. He has defined and implemented successful common sense approaches in manufacturing, design control, supplier control, document control, audits, and other QMS requirement areas. George is a senior member of ASQ for over 25 years. He has attained multiple ASQ certifications including all FDA regulated industry focused accreditation: Certified Biomedical Auditor (CBA) #625, Certified HACCP Auditor (CHA) #925, and Certified Pharmaceutical GMP Professional (CPGP) #313. He is an active member of the ASQ Biomedical Division and the Northern California Biomedical Discussion Group.

REGISTRATION FORM Risk Based Incoming Quality Assurance (IQA) Personal Information of One Registrant Last Name: Mr. Ms. Dr. First Name: Job Title: Organization: Mailing Address: Telephone: Email: Fee: (see fee structure below) 1 attendee $225 2-5 attendees $180 (per attendee)(20% Discount) 6-10 attendees $153 (per attendee)(32% Discount) 11-20 attendees $135 (per attendee)(40% Discount) Method of Payment: Credit Card and Check payments only. Attendees can register and make payments on Microrite s website-www.microrite.com or complete this form and fax to 408-445-1236. Check payments must be cleared before the webinar date. If you have any questions regarding payment methods feel free to contact Microrite at 408-445-0507 or send your enquiry to info@microrite.com. Confirmation of registration will be sent via email. For credit card payment on website, a payment receipt will be considered as confirmation of registration. For credit card information faxed to Microrite an email confirmation will be sent with a copy of payment receipt. Please call 408-445-0507 in due time if confirmation is not received after payment. Webinar cancellation must be received 3 business days prior to the webinar less a 10% service fee, cancellation requests will be accepted via email only. All refund requests must be made by the organizations primary contact or credit card holder. Refunds will be credited to the original credit card used to purchase the webinar.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 First and Last Name Additional Attendees Email

Choose One (Place X) VISA Master Card American Express Card Holder s Name Address of Card Holder: Enter firm address for corporate card or personal address for personal card Street: City/State: Zip Code: Country: Contact Ph No & Email: Card Number: Expiration(Month/Year): Amount (US Dollars): Signature: Name of Attendee(s) Referred by: Kindly note the name of the company or person that referred you to this workshop. We would like to thank them..